The largest database of trusted experimental protocols

Puromycin

Manufactured by GenePharma
Sourced in China

Puromycin is a laboratory reagent commonly used in molecular biology and cell culture experiments. It functions as a selective antibiotic that inhibits protein synthesis in eukaryotic cells. Puromycin is often utilized as a selection marker in genetic engineering experiments to identify and isolate cells that have successfully integrated a target gene of interest.

Automatically generated - may contain errors

18 protocols using puromycin

1

Lentiviral Transduction and GLUT3 Overexpression in PC12 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The lentiviral vectors LV5-EF-GFP-puro (LV5) carrying a green fluorescent protein (GFP) and puromycin-resistance gene (puro) expression cassette were designed as negative controls, and the GLUT3 gene was cloned into LV5 vectors (LV5-GLUT3), which were supplied by GenePharma Co., Ltd., China. Our preliminary results showed that a multiplicity of infection (MOI) of 100 and a puromycin (GenePharma) concentration of 5 ng/ml were the best parameters for further experiments. After 5 days of incubation in 6-cm plates and after the PC12 cells were 60% confluent, 200 µl containing 108 TU LV5-GLUT3/ml was added to each well. GFP expression was observed under a microscope 36 h after transfection to identify the transfection efficiency. puromycin (5 ng/ml) was used to select PC12 cells stably overexpressing GLUT3 for subsequent experiments, and primary neurons were not used for this step.
+ Open protocol
+ Expand
2

Lentiviral Overexpression and Knockdown of miR-218 and RICTOR

Check if the same lab product or an alternative is used in the 5 most similar protocols
The commercial LV3-miR-218 lentivirus vector (pre-miR-218) (containing green fluorescent protein GFP and the puromycin sequence) were constructed by GenePharma (Shanghai, China). An LV3 scrambled lentiviral vector (miR-NC) was used as a negative control. The lentiviral vectors were verified by DNA sequencing. Then the lentiviral vectors were used to infect LNCaP, C4-2 and CWR22RV1 cells at an appropriate multiplicity of infection (MOI) when cells had grown to 40–50% confluence in the presence of 8 μg/ml polybrene. The stable miR-218 overexpression subclones were maintained by using 2–3 μg/ml puromycin-resistant culturing (puromycin, Sigma, USA). After that, cells were analyzed for miR-218 expression using the miRNA real-time quantitive PCR (qPCR) assay described as above.
Lentiviral vectors encoding short hairpin RNA (shRNA) targeting human RICTOR were constructed by GenPharma (Shanghai, China). The specific sequences of shRNA used for targeting human RICTOR were: 5′-GCCGTATACTCCTTCGCAAAG-3′ (#1) and 5′- GCAACCAACTGAGTGCAATAT -3′ (#2). The scrambled lentiviral vector was used as a negative control. The cells were transfected with the lentiviral vectors as above. Afterward, cells were analyzed using real-time quantitive PCR (qPCR) and Western blotting assay for RICTOR expression.
+ Open protocol
+ Expand
3

MTHFD1L Knockdown in TSCC Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
To knockdown the MTHFD1L gene expression, TSCC cell lines (CAL-27, SCC-15) were transfected with specific short hairpin MTHFD1L RNAs (shRNAs, 5′-GGCCAAAGCTGTAATTGAACTTCT-3′ and 5′-GCTCTGTATAATCGGCTGGTTC-3′); the shRNAs were purchased from GenePharma Co., Ltd. (Suzhou, China).
We used established stable cell lines from the CAL-27 and SCC-15 cell lines by selection with 3 μg.mL−1 puromycin for 3 weeks. We purchased adenoviruses from GenePharma Co., Ltd.
+ Open protocol
+ Expand
4

Lentiviral Transduction of miR-1

Check if the same lab product or an alternative is used in the 5 most similar protocols
The pLV-hsa-miR-1 plasmid and the negative control pLV-miRNA-vector were purchased from Shanghai GenePharma Co., Ltd. The viruses were packaged in 293T (Type Culture Collection of the Chinese Academy of Sciences) cells according to standard protocols and the virus particles were harvested 72 h later. The packaged lentiviruses were termed LV-miR-1, while the empty lentiviral vector LV-ctrl was used as a control. Cells were infected with viral particles (MOI = 10 for each) for 24 h and 5 µg/ml Polybrene, which was followed by selection with puromycin (2 µg/ml) for ≤7 days. Polybrene and puromycin were purchased from Shanghai GenePharma Co., Ltd.
+ Open protocol
+ Expand
5

Lentiviral BRD4 Knockdown in Prostate Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
BRD4-targeted shRNA was expressed in a pGLV3/H1/green fluorescent protein (GFP) + Puro lentiviral vector via BamHI and EcoRI; vectors were constructed by Shanghai GenePharma Co., Ltd. (Shanghai, China). The shRNA sequence targeting BRD4 was as follows: 5′-GCTCAAGACACTATGGAAACA-3′, the shRNA sequence used as the negative control (sh-NC) was 5′-TTCTCCGAACGTGTCACGT-3′ (LV3-NC-GFP; Shanghai GenePharma Co., Ltd.). 293 cells (American Type Culture Collection) were cultured in 10 cm plates at a density of 5×105 cells per well with DMEM (Gibco; Thermo Fisher Scientific, Inc.) containing 10% FBS in an incubator at 37°C and 5% CO2 for 48 h. Then lentiviral shRNA-containing plasmids were transfected into 293 cells to generate lentiviruses; the lentiviral supernatant containing the BRD4 shRNA was harvested and purified. DU145 and LNCAP cells were then infected by application of viral supernatant (multiplicity of infection 15 for DU145, multiplicity of infection 20 for LNCAP) in RPMI-1640 culture medium with 10% FBS. The cationic polymer Polybrene (Shanghai GenePharma Co., Ltd.) was added to facilitate transduction. After 24 h following transduction the medium was exchanged and cells were cultured for an additional 48 h. Stable cell lines were selected via the application of 1 µg/ml puromycin (Shanghai GenePharma Co., Ltd.).
+ Open protocol
+ Expand
6

Overexpression and Knockdown of TFAP2B in Thyroid Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
To overexpress TFAP2B in thyroid cancer cells, pcDNA3.1–TFAP2B or control vector plasmids were transfected with EndoFectinTM MAX (GeneCopoeia, Inc., Rockville, MD, USA). To knockdown gene expression, thyroid cancer cells were transfected with specific short hairpin TFAP2B RNA (shRNA, 5′-GGAAGCUUGUGGAGAAUGUTT-3′ and CCCGAAAGAAUAUGCUGUUTT) and COX-2 RNA (shRNA, 5′-AAC UGC UCA ACA CCG GAA Udtdt-3′). The shRNAs were purchased from GenePharma Co., Ltd. (Suzhou, China), and to inhibit COX-2 by the COX-2 inhibitor Celecoxib (purchased from Selleck).
We use KTC-1, Bcpap and TPC-1 cells lines to establish stable cell lines by selection with 1 lg.mL−1 puromycin for 4 weeks, and adenoviruses were purchased from GenePharma Co., Ltd.
+ Open protocol
+ Expand
7

Knockdown of GAB2 in PC-3 Prostate Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
PC-3 human PCa cells from the Cell Bank of Xi'an Jiaotong University were cultured in medium containing 10% fetal bovine serum (Hyclone Laboratories; GE Healthcare Life Sciences), 1% streptomycin mixture and ~90% RPMI-1640 complete medium (Gibco; Thermo Fisher Scientific Inc.). The cells were cultured at a constant temperature of 37°C with 95% O2, and 5% CO2 in an incubator (relative humidity, ~95%). Adherent cells were transfected with GAB2 siRNA as follows: The commercial LV3-GAB2 lentivirus vector (containing green fluorescent protein and the puromycin sequence) and GAB2 siRNA sequences were constructed by Shanghai GenePharma Co., Ltd. The sequence of GAB2 siRNA was 5′-GGGACCTCCTGGTAGACAATA-3′, and the sequence of scrambled fluorescein-labeled negative control siRNA was: 5′-TTCTCCGAACGTGTCACGT-3′. When cells reached 40–50% confluence in the presence of 8 µg/ml polypropylene, lentiviral vectors were used to infect PC-3 cells at 50 multiplicity of infection for 72 h. The stable GAB2 low expression level subclones were maintained via 2–3 µg/ml puromycin-resistant culturing (puromycin, Sigma-Aldrich; Merck KGaA). PC-3 human PCa cells transfected with negative control (NC) siRNA were used as the NC group, and cells transfected with GAB2 siRNA were used as the knockdown (KD) group. Three samples in each group were subjected to gene chip analysis.
+ Open protocol
+ Expand
8

Lentiviral Modulation of miR-210-5p and PIK3R5 in Osteosarcoma

Check if the same lab product or an alternative is used in the 5 most similar protocols
LV2-has-miR-210-5p-mimic vector (LV-miR-210-5p) and the LV2- has-miR-210-5p-inhibitor vector (ANTI-miR-210-5p) were constructed using lentiviral vectors (GenePharma, Shanghai, China). Negative controls with the LV2 empty lentivirus (LV-NC and ANTI-NC) were also constructed. We infected OS cells grown to 40–50% confluence using lentiviral vectors at an appropriate multiplicity of infection. Puromycin (5 μg/ml, Sigma Aldrich) was used in selected transfected OS cells to generate stable OS cell lines. Vectors for overexpressing and downregulating target human PIK3R5 using lentiviral gene transfer and containing the Puromycin-resistance sequence were constructed by GenePharma (Shanghai, China), and the scrambled lentiviral construct was used as a negative control. OS cells were transfected with the lentiviral vectors (Vector, PIK3R5, shNC, and shPIK3R5). Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) and western blot analysis were then used to confirm PIK3R5 expression.
+ Open protocol
+ Expand
9

Lentiviral Vectors for Colon Cancer Cell Fusion

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant lentiviral vectors encoding green fluorescent protein (GFP) and red fluorescent protein (RFP) genes were constructed using gene recombination technology. GFP and RFP genes were then introduced into human colon cancer cells to establish human colon cancer cell lines with stable expression of GFP and RFP (LoVo-GFP, LoVo-RFP, Hct116-GFP, and Hct116-RFP cells). Lentivirus negative control (NC) venom concentrate was synthesized by Gene-Pharma (Shanghai, China). Cells were selected using puromycin (Gene-Pharma, Shanghai, China). To visualize cell fusion in the formation of PGCC, human colon cancer cells with stable expression of GFP and RFP (LoVo and Hct116 cells) were co-cultured, i.e., LoVo-GFP cells were co-cultured with LoVo-RFP cells and Hct116-GFP cells were co-cultured with Hct116-RFP cells. PGCCs were generated from the co-cultured colon cancer cells expressing GFP and RFP after induction by ATO. Cell fusion of colon cancer cells was visualized as yellow fluorescence in the co-cultured colon cancer cells expressing GFP and RFP under a fluorescence microscope.
+ Open protocol
+ Expand
10

Visualizing Nuclear Fusion in Colon Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant lentiviral vectors encoding the human histone H2B-GFP and H2B-mCherry genes were constructed using gene recombination technology. Recombinant lentiviral vectors were synthesized by Gene-Pharma (Shanghai, China). Recombinant lentiviral vectors expressing H2B-GFP and H2B-mCherry were transfected into human colon cancer cells (LoVo and Hct116 cells) to obtain a stable cell line expressing H2B-GFP and H2B-mCherry. Cells were selected using puromycin (Gene-Pharma, Shanghai, China). To visualize nuclear fusion during the formation of PGCC, human colon cancer cells with stable expression of H2B-GFP and H2B-mCherry were co-cultured, i.e., LoVo-H2B-GFP cells were co-cultured with LoVo-H2B-mCherry cells and Hct116-H2B-GFP cells were co-cultured with Hct116-H2B-mCherry cells. PGCCs were generated from the co-cultured colon cancer cells expressing H2B-GFP and H2B-mCherry after induction by ATO. Nuclear fusion of colon cancer cells was visualized as yellow fluorescence in the co-cultured colon cancer cells expressing GFP and RFP under a fluorescence microscope.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!